Insmed Inc. buy Cantor Fitzgerald
Start price
19.09.23
/
50%
€24.40
Target price
19.09.24
€43.04
Performance (%)
172.54%
End price
20.09.24
€66.50
Summary
This prediction ended on 20.09.24 with a price of €66.50. With a performance of 172.54% the BUY prediction by Cantor_Fitzgerald was a big success. Cantor_Fitzgerald has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -5.983% | -5.983% | 86.492% |
| iShares Core DAX® | -1.424% | 8.918% | 7.311% |
| iShares Nasdaq 100 | 3.274% | 16.275% | 36.651% |
| iShares Nikkei 225® | 1.745% | 16.239% | 46.602% |
| iShares S&P 500 | 1.447% | 10.913% | 27.166% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $46.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten